StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Loan & DebtAug 12, 2026, 05:24 PM

Scilex Establishes $20M Revolving Line of Credit for Vivasor

AI Summary

Scilex Holding Company entered into a Promissory Note (Revolving Line of Credit) with Vivasor, Inc., establishing an uncommitted line of credit for up to $20,000,000. The note has a maturity of 120 months and an interest rate of 5% per annum. Scilex retains sole discretion on funding any drawdowns, which can be made in cash, its own securities, or Datavault AI common shares. This transaction involves a related party, as Scilex's CEO also serves as Vivasor's CEO.

Key Highlights

  • Scilex established an uncommitted revolving line of credit for Vivasor, Inc. up to $20,000,000.
  • The promissory note has a maturity date of 120 months from August 8, 2026.
  • Borrowings under the note will bear interest at a rate of 5% per annum.
  • Scilex has sole discretion and no obligation to fund any drawdown requests.
  • Funding for drawdowns can be in cash, Scilex securities, Datavault AI common shares, or a combination.
  • Dr. Henry Ji, Scilex's CEO, President, and Chairperson, also serves as Vivasor's CEO.